Stratelus is conducting research activities focused at advancement of diagnostics of eye tumours.  Differential diagnosis of human eye tumours is one of the most important problems in ophthalmology in dealing with cancer prevention and diagnostics. Malignant eye tumours make 0.2 per cent of all malignant tumours diagnosed, but it is a direct reason of death for each third patient. In ophthalmological practice and treatment, intraocular tumour differentiation is one of determinant factors for management and outcomes of a disease. Stratelus and our associates are working on improvement of methodologies and, together with our partners in the Eurostars NICDIT project, on development of a device that will enable a more advanced diagnostics.

Eye fundus recognition in diabetic retinopathy is an ongoing project.